FDA Investigator: Dustin P. Tran
- Dustin P. Tran first started conducting FDA inspections in 2016, with the last inspection in 2022. Over that time, Dustin P. Tran has conducted 85 inspections at 82 companies across 83 sites.
Get Dustin Tran's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Elaine E. Tseng, M.D, San Francisco | January 2022
Available Now - $199
Dustin P. Tran
Medical Devices & Rad Health Form 483
FDA 483 Leila Chaychi, M.D, San Carlos | October 2021
Available Now - $199
Dustin P. Tran
Human Drug Form 483
FDA 483 Edward C. Hsiao, M.D., Ph.D, San Francisco | 2021
Available Now - $199
Dustin P. Tran
Human Drug Form 483
FDA EIR Edward C. Hsiao, M.D., Ph.D, San Francisco | 2021
Available Now - $995
Dustin P. Tran
Human Drug Form 483
FDA 483 Innova Medical Group, Pasadena | April 2021
Available Now - $199
Dustin P. Tran
Medical Devices & Rad Health Form 483
FDA 483 Michael L. Levin, M.D, Las Vegas | November 2020
Available Now - $199
Dustin P. Tran
Biologic Form 483
FDA 483 Steiner Biotechnology, Henderson | June 2019
Available Now - $199
Dustin P. Tran
Medical Devices & Rad Health Form 483
FDA 483 Comparative Biosciences, Sunnyvale | May 2019
Available Now - $199
Dustin P. Tran
Human Drug Form 483
FDA 483 Philip D. Darney, M.D, San Francisco | December 2017
Available Now - $199
Dustin P. Tran
Human Drug Form 483
FDA 483 Ron Gallemore, M.D., Ph.D, Torrance | July 2017
Available Now - $199
Dustin P. Tran
Human Drug Form 483
FDA 483 BioMarin Pharmaceutical Inc., San Rafael | 2020
Out-of-stock
Dustin P. Tran
Human Drug Form 483
FDA 483 AcelRx Pharmaceuticals, Inc., Redwood City | 2020
Out-of-stock
Dustin P. Tran
Human Drug Form 483
FDA 483 Lovelace Biomedical Research Institute, Albuquerque | 2019
Out-of-stock
Dustin P. Tran
Human Drug Form 483
FDA 483 BioSurg, Inc., Winters | 2019
Out-of-stock
Dustin P. Tran
Medical Devices & Rad Health Form 483
Co-Investigators (36)
- Linh Tu, FDA Investigator
- Rebecca T. Davis, FDA Investigator
- Humberto Z. Gomez, FDA Investigator
- Sunitha K. Rajaram, FDA Investigator
- Janet Pulver, FDA Investigator
- Marlo-Ian M. Alintanahin, FDA Investigator
- Juanita Banuelos, FDA Investigator
- Dustin R. Abaonza, FDA Investigator
- Karen M. Montgomery, FDA Investigator
- Stephen T. Hansen, FDA Investigator
- Haley H. Seymour, FDA Investigator
- Dipti Kalra, FDA Investigator
- Gene R. Gunn, FDA Investigator
- Jeanne J. Thai, FDA Investigator
- Debra L. Boyd Seale, FDA Investigator
- Boyd Seale, Debra L, FDA Investigator
- Ruth A. Williams, FDA Investigator
- Zhou Chen, FDA Investigator
- Stefanie R. Cook, FDA Investigator
- Sajin Bae, FDA Investigator
- Joan T. Briones, FDA Investigator
- Bei Yu, FDA Investigator
- Yiyue Zhang, FDA Investigator
- Stuart W. Russell, FDA Investigator
- Susan K. Cummins, FDA Investigator
- Shelley H. Beausoleil, FDA Investigator
- Andrew T. Todd, FDA Investigator
- Steven M. Galvez, FDA Investigator
- Maridali De Leon-Torres, FDA Investigator
- Joseph Tibay, FDA Investigator
- Andrew E. Kay, FDA Investigator
- Emal Wahab, FDA Investigator
- Jennifer Crumb, FDA Investigator
- Eileen A. Liu, FDA Investigator
- David Eng, FDA Investigator
- Ashar P. Parikh, FDA Investigator